Skip to main content
Erschienen in: Medical Oncology 9/2021

01.09.2021 | Original Paper

Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer

verfasst von: Johann Ebadfardzadeh, Mandana Kazemi, Ali Aghazadeh, Monireh Rezaei, Milad Shirvaliloo, Roghayeh Sheervalilou

Erschienen in: Medical Oncology | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

The third leading cause of cancer-related deaths in the world, colorectal cancer (CRC) is a global health issue that should be addressed in both diagnostics and therapeutics to improve patient survival rate. Today, microarray data analysis is increasingly being used as a novel and effective method for classification of malignancies and making prognostic assessments. Built upon the concept of microarray data analysis and aimed at the identification of CRC-associated genes, our study has adopted an integrative analysis for the gene expression patterns of four microarray datasets in gene expression omnibus (GEO) and microRNAs (miRNAs) expression profiles. We downloaded four gene expression profiles, i.e., GSE37182, GSE25070, GSE10950, and GSE113513, miRNAs gene expression profiles and differentially expressed genes (DEGs). We used R software, the DAVID database, protein–protein interaction (PPI) networks, the Cytoscape program and receiver operating characteristic (ROC) curve for data analysis. Out of the four gene expression profiles, a total of 43 common DEGs were identified, including 10 hub genes, SLC26A3, CLCA1, GUCA2A, MS4A12, CLCA4, GUCA2B, KRT20, AQP8, MAOA, and ADH1A, and four differentially expressed miRNAs, miR-552, miR-423-5p, miR-502-3p, and miR-490-5p. The highly enriched modes of the signaling pathways among these DEGs were speculated to be involved in various processes including nitrogen metabolism, mineral absorption, pancreatic secretions, and tyrosine metabolism in Kyoto encyclopedia of genes and genomes (KEGG) database. According to our bioinformatics analysis, the DEGs identified in the present study could be considered as significant hallmarks in the molecular mechanisms of CRC development. Our findings may assist scientists with developing novel strategies not only for prediction of CRC, but also for screening and early diagnosis, and treatment of CRC patients.
Literatur
2.
Zurück zum Zitat Hinoue T, Shen H, Weisenberger DJ, Laird PW, Byun HM, Van Den Berg D, Malik S, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012;22:271–282.PubMedPubMedCentralCrossRef Hinoue T, Shen H, Weisenberger DJ, Laird PW, Byun HM, Van Den Berg D, Malik S, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012;22:271–282.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Eynali S, Khoei S, Khoee S, Esmaelbeygi E. Evaluation of the cytotoxic effects of hyperthermia and 5-fluorouracil-loaded magnetic nanoparticles on human colon cancer cell line HT-29. Int J Hyperth. 2017;33:327–35.CrossRef Eynali S, Khoei S, Khoee S, Esmaelbeygi E. Evaluation of the cytotoxic effects of hyperthermia and 5-fluorouracil-loaded magnetic nanoparticles on human colon cancer cell line HT-29. Int J Hyperth. 2017;33:327–35.CrossRef
4.
Zurück zum Zitat Kijima S, Sasaki T, Nagata K, Utano K, Lefor AT, Sugimoto H. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. WJG. 2014;20:16964.PubMedPubMedCentralCrossRef Kijima S, Sasaki T, Nagata K, Utano K, Lefor AT, Sugimoto H. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. WJG. 2014;20:16964.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Brenner H, Kloor M, Peter Pox C. Colorectal cancer. The Lancet. 2014;383:1490–502.CrossRef Brenner H, Kloor M, Peter Pox C. Colorectal cancer. The Lancet. 2014;383:1490–502.CrossRef
6.
Zurück zum Zitat Ohhara Y, Fukuda N, Takeuchi S, Honma R, Shimizu Y, Kinoshita I, Dosaka-Akita H. Role of targeted therapy in metastatic colorectal cancer. World J Gastrointest Oncol. 2016;8:642.PubMedPubMedCentralCrossRef Ohhara Y, Fukuda N, Takeuchi S, Honma R, Shimizu Y, Kinoshita I, Dosaka-Akita H. Role of targeted therapy in metastatic colorectal cancer. World J Gastrointest Oncol. 2016;8:642.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Watanabe T, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y, Hamaguchi T, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1–34.PubMedCrossRef Watanabe T, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y, Hamaguchi T, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1–34.PubMedCrossRef
8.
Zurück zum Zitat Austin H, Henley SJ, King J, Richardson LC, Eheman C. Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening. Cancer Causes Control. 2014;25:191–201.PubMedCrossRef Austin H, Henley SJ, King J, Richardson LC, Eheman C. Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening. Cancer Causes Control. 2014;25:191–201.PubMedCrossRef
10.
Zurück zum Zitat Chen H, Sun X, Ge W, Qian Y, Bai R, Zheng S. A seven-gene signature predicts overall survival of patients with colorectal cancer. Oncotarget. 2017;8:95054.PubMedCrossRef Chen H, Sun X, Ge W, Qian Y, Bai R, Zheng S. A seven-gene signature predicts overall survival of patients with colorectal cancer. Oncotarget. 2017;8:95054.PubMedCrossRef
11.
Zurück zum Zitat Collisson E, Muzny D, Bainbridge M, Chang K, Dinh H, Drummond J, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.CrossRef Collisson E, Muzny D, Bainbridge M, Chang K, Dinh H, Drummond J, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.CrossRef
12.
Zurück zum Zitat Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, Biasco G. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev. 2009;35:201–9.PubMedCrossRef Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, Biasco G. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev. 2009;35:201–9.PubMedCrossRef
14.
Zurück zum Zitat Gao L, Yang X, Zhang H, Yu M, Long J, Yang T. Inhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathway. OTT. 2018;11:6981–94.CrossRef Gao L, Yang X, Zhang H, Yu M, Long J, Yang T. Inhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathway. OTT. 2018;11:6981–94.CrossRef
15.
Zurück zum Zitat Huang H-Y, Lin Y-C-D, Li J, Huang K-Y, Shrestha S, Hong H-C, Tang Y, et al. miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database. Nucleic Acids Res. 2020;2020(48):D148–54. Huang H-Y, Lin Y-C-D, Li J, Huang K-Y, Shrestha S, Hong H-C, Tang Y, et al. miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database. Nucleic Acids Res. 2020;2020(48):D148–54.
16.
17.
Zurück zum Zitat Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–79.PubMedCrossRef Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–79.PubMedCrossRef
18.
Zurück zum Zitat Musella V, Verderio P, Reid JF, Pizzamiglio S, Gariboldi M, Callari M, Massimo M, et al. Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PloS one. 2013;8:e53406.PubMedPubMedCentralCrossRef Musella V, Verderio P, Reid JF, Pizzamiglio S, Gariboldi M, Callari M, Massimo M, et al. Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PloS one. 2013;8:e53406.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun H-M, Van Den Berg D, Malik S, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 2012;22:271–82.PubMedPubMedCentralCrossRef Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun H-M, Van Den Berg D, Malik S, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 2012;22:271–82.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Jiang X, Tan J, Li J, Kivimäe S, Yang X, Zhuang L, Lee PL, et al. DACT3 is an epigenetic regulator of Wnt/β-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell. 2008;13:529–41.PubMedPubMedCentralCrossRef Jiang X, Tan J, Li J, Kivimäe S, Yang X, Zhuang L, Lee PL, et al. DACT3 is an epigenetic regulator of Wnt/β-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell. 2008;13:529–41.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Slattery ML, Herrick JS, Pellatt DF, Stevens JR, Mullany LE, Wolff E, Hoffman MD, et al. MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression. Carcinogenesis. 2016;37:245–61.PubMedPubMedCentralCrossRef Slattery ML, Herrick JS, Pellatt DF, Stevens JR, Mullany LE, Wolff E, Hoffman MD, et al. MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression. Carcinogenesis. 2016;37:245–61.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Balaguer F, Moreira L, Lozano JJ, Link A, Ramirez G, Shen Y, Cuatrecasas M, et al. Colorectal cancers with microsatellite instability display unique miRNA profiles. Clin Cancer Res. 2011;17:6239–49.PubMedPubMedCentralCrossRef Balaguer F, Moreira L, Lozano JJ, Link A, Ramirez G, Shen Y, Cuatrecasas M, et al. Colorectal cancers with microsatellite instability display unique miRNA profiles. Clin Cancer Res. 2011;17:6239–49.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25–9.PubMedPubMedCentralCrossRef Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25–9.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Altermann E, Klaenhammer TR. PathwayVoyager: pathway mapping using the Kyoto encyclopedia of genes and genomes (KEGG) database. BMC Genom. 2005;6:1–7.CrossRef Altermann E, Klaenhammer TR. PathwayVoyager: pathway mapping using the Kyoto encyclopedia of genes and genomes (KEGG) database. BMC Genom. 2005;6:1–7.CrossRef
25.
Zurück zum Zitat Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44.PubMedCrossRef Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44.PubMedCrossRef
26.
Zurück zum Zitat Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–52.PubMedCrossRef Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–52.PubMedCrossRef
28.
Zurück zum Zitat Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.PubMedPubMedCentralCrossRef Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 2016;44:D336–42.PubMedCrossRef Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 2016;44:D336–42.PubMedCrossRef
31.
33.
Zurück zum Zitat Huo F, Kang J, Zhang Y, Yin C. A specific fluorescent probe for zinc ion based on thymolphthalein and it’s application in living cells. Sens Actuators B Chem. 2018;262:263–9.CrossRef Huo F, Kang J, Zhang Y, Yin C. A specific fluorescent probe for zinc ion based on thymolphthalein and it’s application in living cells. Sens Actuators B Chem. 2018;262:263–9.CrossRef
34.
Zurück zum Zitat Ishida T. Anti-cancer effects of zinc (II) ion in tumor formation and growth, proliferation, metastasis and DNA damage. Degener Intellect Dev Disabil. 2017;1:1–7. Ishida T. Anti-cancer effects of zinc (II) ion in tumor formation and growth, proliferation, metastasis and DNA damage. Degener Intellect Dev Disabil. 2017;1:1–7.
35.
Zurück zum Zitat Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteom. 2010;73:1907–20.CrossRef Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteom. 2010;73:1907–20.CrossRef
36.
Zurück zum Zitat Keshet R, Szlosarek P, Carracedo A, Erez A. Rewiring urea cycle metabolism in cancer to support anabolism. Nat Rev Cancer. 2018;18:634–45.PubMedCrossRef Keshet R, Szlosarek P, Carracedo A, Erez A. Rewiring urea cycle metabolism in cancer to support anabolism. Nat Rev Cancer. 2018;18:634–45.PubMedCrossRef
37.
Zurück zum Zitat Ostasiewicz B, Ostasiewicz P, Duś-Szachniewicz K, Ostasiewicz K, Ziółkowski P. Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation. Mol Med Rep. 2016;13:5084–92.PubMedPubMedCentralCrossRef Ostasiewicz B, Ostasiewicz P, Duś-Szachniewicz K, Ostasiewicz K, Ziółkowski P. Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation. Mol Med Rep. 2016;13:5084–92.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Li X, Hu W, Zhou J, Huang Y, Peng J, Yuan Y, Yu J, et al. CLCA1 suppresses colorectal cancer aggressiveness via inhibition of the Wnt/beta-catenin signaling pathway. Cell Commun Signaling. 2017;15:1–13.CrossRef Li X, Hu W, Zhou J, Huang Y, Peng J, Yuan Y, Yu J, et al. CLCA1 suppresses colorectal cancer aggressiveness via inhibition of the Wnt/beta-catenin signaling pathway. Cell Commun Signaling. 2017;15:1–13.CrossRef
40.
Zurück zum Zitat He L, Deng H. Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer. Neoplasma. 2017;64:65–73.PubMedCrossRef He L, Deng H. Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer. Neoplasma. 2017;64:65–73.PubMedCrossRef
41.
Zurück zum Zitat Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, et al. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. J Exp Clin Cancer Res. 2015;34:1–10.CrossRef Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, et al. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. J Exp Clin Cancer Res. 2015;34:1–10.CrossRef
42.
Zurück zum Zitat Cao J, Yan XR, Liu T, Han XB, Yu JJ, Liu SH, Wang LB. MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer. Oncol Lett. 2017;14:3795–802.PubMedPubMedCentralCrossRef Cao J, Yan XR, Liu T, Han XB, Yu JJ, Liu SH, Wang LB. MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer. Oncol Lett. 2017;14:3795–802.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Kwak B, Kim DU, Kim TO, Kim H-S, Kim S-W. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer. Int J Oncol. 2018;53:1800–8.PubMed Kwak B, Kim DU, Kim TO, Kim H-S, Kim S-W. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer. Int J Oncol. 2018;53:1800–8.PubMed
45.
Zurück zum Zitat Fesler A, Liu H, Wu N, Liu F, Ling P, Ju J. Autophagy regulated by miRNAs in colorectal cancer progression and resistance. Cancer Transl Med. 2017;3:96.PubMedPubMedCentralCrossRef Fesler A, Liu H, Wu N, Liu F, Ling P, Ju J. Autophagy regulated by miRNAs in colorectal cancer progression and resistance. Cancer Transl Med. 2017;3:96.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Li Y, Gong Y, Ma J, Gong X. Overexpressed circ-RPL15 predicts poor survival and promotes the progression of gastric cancer via regulating miR-502–3p/OLFM4/STAT3 pathway. Biomed Pharm. 2020;127:110219.CrossRef Li Y, Gong Y, Ma J, Gong X. Overexpressed circ-RPL15 predicts poor survival and promotes the progression of gastric cancer via regulating miR-502–3p/OLFM4/STAT3 pathway. Biomed Pharm. 2020;127:110219.CrossRef
47.
Zurück zum Zitat Xiang M, Yuan W, Zhang W, Huang J. Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells. Oncol Lett. 2019;17:4437–42.PubMedPubMedCentral Xiang M, Yuan W, Zhang W, Huang J. Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells. Oncol Lett. 2019;17:4437–42.PubMedPubMedCentral
Metadaten
Titel
Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer
verfasst von
Johann Ebadfardzadeh
Mandana Kazemi
Ali Aghazadeh
Monireh Rezaei
Milad Shirvaliloo
Roghayeh Sheervalilou
Publikationsdatum
01.09.2021
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 9/2021
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-021-01543-5

Weitere Artikel der Ausgabe 9/2021

Medical Oncology 9/2021 Zur Ausgabe

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Brustkrebs-Prävention wird neu gedacht

04.06.2024 ASCO 2024 Kongressbericht

Zurzeit untersuchen Forschende verschiedene neue Ansätze zur Prävention von Brustkrebs bei Personen mit hohem Risiko. Darunter Denosumab, die prophylaktische Bestrahlung der Brust – und Impfungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.